🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, claiming the firms withheld alleged dangers that the medication created to children's brain development.

This legal action follows a month after President Donald Trump advocated an unproven link between consuming Tylenol - alternatively called paracetamol - while pregnant and autism spectrum disorder in young ones.

Paxton is suing the pharmaceutical giant, which previously sold the medication, the only pain reliever approved for expectant mothers, and Kenvue, which currently produces it.

In a declaration, he said they "deceived the public by profiting off of pain and pushing pills regardless of the dangers."

The company asserts there is insufficient reliable data connecting acetaminophen to autism.

"These companies misled for generations, deliberately risking numerous people to boost earnings," Paxton, from the Republican party, declared.

The manufacturer commented that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the potential impact that could have on the welfare of US mothers and children."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a established connection between taking acetaminophen and autism."

Organizations representing medical professionals and healthcare providers agree.

ACOG has stated paracetamol - the key substance in acetaminophen - is among limited choices for women during pregnancy to treat discomfort and elevated temperature, which can create major wellness concerns if left untreated.

"In over twenty years of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of acetaminophen in any stage of pregnancy causes neurological conditions in young ones," the organization said.

The lawsuit cites recent announcements from the former administration in arguing the medication is allegedly unsafe.

Recently, Trump caused concern from health experts when he told expectant mothers to "struggle intensely" not to use Tylenol when unwell.

The US Food and Drug Administration then issued a notice that doctors should consider limiting the usage of Tylenol, while also mentioning that "a causal relationship" between the medication and autism spectrum disorder in young ones has not been established.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in spring to undertake "a massive testing and research effort" that would identify the origin of autism in a matter of months.

But authorities warned that finding a single cause of autism - thought by researchers to be the result of a complex mix of genetic and surrounding conditions - would prove challenging.

Autism is a form of permanent neurological difference and disability that influences how persons encounter and interact with the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is seeking the Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

The case attempts to require the firms "destroy any marketing or advertising" that states Tylenol is secure for women during pregnancy.

The Texas lawsuit mirrors the concerns of a group of guardians of children with autism spectrum disorder and ADHD who took legal action against the producers of acetaminophen in two years ago.

The court threw out the legal action, saying studies from the plaintiffs' authorities was not conclusive.